2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT)
CUSIP: 901384107
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 52,406,487
- Total 13F shares
- 95,972
- Share change
- -47,238,441
- Total reported value
- $507,987
- Price per share
- $9.92
- Number of holders
- 2
- Value change
- -$233,368,571
- Number of sells
- 135
Quarterly Holders Quick Answers
What is CUSIP 901384107?
CUSIP 901384107 identifies TSVT - 2seventy bio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 901384107:
Top shareholders of TSVT - 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
10,284,222
|
$61,293,964 | — | 10 Aug 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
13D/G
|
Company · THE GOLDMAN SACHS GROUP, INC. |
0%
from 13D/G
|
4,681,675
|
$23,127,474 | — | 31 Mar 2025 | |
| Beryl Capital Management LLC |
13F
|
Company |
8.1%
|
4,250,000
|
$20,995,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
7.6%
|
3,971,873
|
$19,621,051 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
5.7%
|
2,967,078
|
$14,657,367 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
5.4%
|
2,819,469
|
$14,069,150 | $0 | 31 Mar 2025 | |
| Casdin Capital, LLC |
3/4/5
13F
|
Director · Company |
3.8%
from 13F
|
2,571,459
mixed-class rows
|
$12,893,491 | — | 13 May 2025 | |
| Newtyn Management, LLC |
13F
|
Company |
4.8%
|
2,534,836
|
$12,522,090 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
4.8%
|
2,516,505
|
$12,431,535 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
4.8%
|
2,497,526
|
$12,337,778 | — | 31 Mar 2025 | |
| Man Group plc |
13F
|
Company |
3.9%
|
2,043,026
|
$10,092,549 | — | 31 Mar 2025 | |
| GLAZER CAPITAL, LLC |
13F
|
Company |
2.5%
|
1,328,166
|
$6,561,000 | — | 31 Mar 2025 | |
| REGENERON PHARMACEUTICALS, INC. |
13F
|
Company |
2.4%
|
1,254,827
|
$6,198,845 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,207,345
|
$5,965,821 | — | 31 Mar 2025 | |
| First Trust Capital Management L.P. |
13F
|
Company |
2.2%
|
1,143,962
|
$5,651,172 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
1,069,815
|
$5,284,886 | — | 31 Mar 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
1.5%
|
800,000
|
$3,952,000 | — | 31 Mar 2025 | |
| Engine Capital Management, LP |
13F
|
Company |
1.3%
|
703,972
|
$3,477,622 | — | 31 Mar 2025 | |
| Madison Avenue Partners, LP |
13F
|
Company |
1.1%
|
579,895
|
$2,864,681 | — | 31 Mar 2025 | |
| Groupe la Francaise |
13F
|
Individual |
0.92%
|
480,000
|
$2,378,400 | — | 31 Mar 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.88%
|
460,000
|
$2,272,400 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.82%
|
429,252
|
$2,120,505 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
417,950
|
$2,064,673 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.77%
|
406,055
|
$2,005,948 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.76%
|
398,910
|
$1,970,615 | — | 31 Mar 2025 | |
| GARDNER LEWIS ASSET MANAGEMENT L P |
13F
|
Company |
0.76%
|
395,936
|
$1,955,924 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.75%
|
394,013
|
$1,946,424 | — | 31 Mar 2025 | |
| DeepCurrents Investment Group LLC |
13F
|
Company |
0.74%
|
390,169
|
$1,927,435 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.71%
|
371,630
|
$1,835,852 | — | 31 Mar 2025 | |
| Philip D. Gregory |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
469,155
mixed-class rows
|
$1,789,046 | — | 05 Jan 2024 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.67%
|
352,739
|
$1,742,531 | — | 31 Mar 2025 | |
| CREDIT INDUSTRIEL ET COMMERCIAL |
13F
|
Individual |
0.61%
|
320,000
|
$1,580,800 | — | 31 Mar 2025 | |
| MONIMUS CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.57%
|
296,260
|
$1,463,524 | — | 31 Mar 2025 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.48%
|
252,500
|
$1,247,350 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.46%
|
243,434
|
$1,202,564 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.41%
|
215,494
|
$1,064,540 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.41%
|
212,298
|
$1,048,752 | — | 31 Mar 2025 | |
| ABC ARBITRAGE SA |
13F
|
Company |
0.38%
|
200,792
|
$991,912 | — | 31 Mar 2025 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
0.37%
|
192,450
|
$950,703 | — | 31 Mar 2025 | |
| BCK CAPITAL MANAGEMENT LP |
13F
|
Company |
0.36%
|
191,000
|
$943,540 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.34%
|
180,057
|
$889,482 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.29%
|
151,136
|
$746,613 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.28%
|
147,663
|
$729,455 | — | 31 Mar 2025 | |
| William D. Baird III |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
176,000
|
$691,680 | — | 13 May 2025 | |
| Sagefield Capital LP |
13F
|
Company |
0.22%
|
115,889
|
$572,492 | — | 31 Mar 2025 | |
| WATER ISLAND CAPITAL LLC |
13F
|
Company |
0.2%
|
104,006
|
$513,790 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.2%
|
103,648
|
$512,020 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.2%
|
102,512
|
$506,409 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.18%
|
94,272
|
$465,704 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.16%
|
84,817
|
$418,984 | — | 31 Mar 2025 |
Institutional Holders of 2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) as of Q2 2025
As of 30 Jun 2025,
2seventy bio, Inc. - Common Stock, par value $0.0001 per share (TSVT) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,972 shares.
The largest 2 holders included
Nuveen, LLC and OSAIC HOLDINGS, INC..
This page lists
2
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
135
Q2 2025 holders
2
Holder diff
-133
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.